Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2003
08/28/2003WO2003070221A1 Chemosensitizing with liposomes containing oligonucleotides
08/28/2003WO2003070197A2 RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070193A2 RNA INTERFERENCE MEDIATED INHIBITION OF HIV GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070192A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003WO2003070190A2 Surrogate antibodies and methods of preparation and use thereof
08/28/2003WO2003070189A2 Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein
08/28/2003WO2003070188A2 Method of treating trx mediated diseases
08/28/2003WO2003070171A2 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
08/28/2003WO2003070160A2 Antisense modulation of protein expression
08/28/2003WO2003069984A2 Transgenic production in saliva
08/28/2003WO2003069980A2 Precise breeding
08/28/2003WO2003069979A2 Plant preparations
08/28/2003WO2003069978A2 Methods for altering organ mass in plants
08/28/2003WO2003062273A3 Modulator of the notch signalling pathway and use thereof in medical treatment
08/28/2003WO2003060136A3 D-galacturonate reductase of fragaria ananassa and its use in methods for increasing production of vitamin c in plants
08/28/2003WO2003055911A3 Cystine-knot fold protein
08/28/2003WO2003048314A3 Direct write nanolithographic deposition of nucleic acids from nanoscopic tips
08/28/2003WO2003046163A3 Multifunctional caffeic acid o-methyltransferase
08/28/2003WO2003044213A3 Cell and tissue arrays and microarrays and methods of use
08/28/2003WO2003044177A3 Multiplex pcr
08/28/2003WO2003043986A8 Polypeptides of moraxella (branhamella) catarrhalis
08/28/2003WO2003038079A3 A mammalian mucinase, its recombinant production, and its use in therapy or prophylaxis against diseases in which mucus is involved or infectious diseases
08/28/2003WO2003033713A3 Production of oil with higher erucic acid content
08/28/2003WO2003031611A3 Phagemid display system
08/28/2003WO2003029289A3 Fragements of heat shock proteins and their use
08/28/2003WO2003025183A3 Random integration of a polynucleotide after in vivo linearization
08/28/2003WO2003025018A3 Dimeric and multimeric antigen binding structure
08/28/2003WO2003025015A3 A soluble toll-like receptor
08/28/2003WO2003023009A3 G-protein coupled receptors
08/28/2003WO2003022858A3 Method for screening for inhibitors of protein/protein interaction and corresponding ribozymes
08/28/2003WO2003020912A3 Novel clark protein and nucleic acid molecules and uses therefor
08/28/2003WO2003020905A3 Nucleic acid compositions conferring disease resistance
08/28/2003WO2003020894A3 Insulin related transcription factor and uses thereof
08/28/2003WO2003020757A3 Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation
08/28/2003WO2003018631A3 Nogo receptor homologues and their use
08/28/2003WO2003016522A3 Methods and compounds for the targeting of protein to exosomes
08/28/2003WO2003014161A3 Antigen binding domains from fish
08/28/2003WO2003014153A3 Cellular virus receptors and methods of use.
08/28/2003WO2003014148A3 Human fatty acid-coa ligase
08/28/2003WO2003012114A3 Methods of rna and protein synthesis
08/28/2003WO2003010318A3 Desulfoglucosinolate sulfotransferases, sequences coding the same and uses thereof for modulating glucosinolate biosynthesis in plants
08/28/2003WO2003006659A3 Plant transcriptional repressor, proteic nuclear factors binding thereto, and uses thereof
08/28/2003WO2003005957A3 Mutants of clostridium septicum alpha toxin and vaccines, antibodies, sera, and methods of treatment therewith
08/28/2003WO2003004674A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
08/28/2003WO2003004619A3 Nucleic acids encoding glucosinolate biosynthesis enzymes and methods of their use
08/28/2003WO2002102990A3 Fibroblast growth factor and nucleic acid encoding same
08/28/2003WO2002101043A3 Regulation of human ta4 receptor
08/28/2003WO2002101026A3 Methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms
08/28/2003WO2002099383A3 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
08/28/2003WO2002099106A3 Regulation of human secretin -type gpcr
08/28/2003WO2002099082A3 Expression of spider silk proteins in higher plants
08/28/2003WO2002097051A3 Protein arrays and methods and systems for producing the same
08/28/2003WO2002097044A3 Alternative splice forms of proteins as basis for multiple therapeutic modalities
08/28/2003WO2002096468A3 Method for the diagnosis and therapy of renal cell carcinoma
08/28/2003WO2002094192A3 Antibodies against tumor necrosis factor delta (april)
08/28/2003WO2002092818A3 Streptococcus agalactiae genome sequence, use for developing vaccines, diagnostic tools, and for identifying therapeutic targets
08/28/2003WO2002090557A3 Freeze-tolerant eukaryotic cells
08/28/2003WO2002088382A3 Method for analysing nucleic acid chains
08/28/2003WO2002088362A3 Regulation of human prostaglandin-f synthase 1-like protein
08/28/2003WO2002088345A3 Murine dnasex, medicament containing the same and non-human mammal comprising modified dnasex gene
08/28/2003WO2002088328A3 Method for generating highly active human dendritic cells from monocytes
08/28/2003WO2002086140A3 Double-strand nucleic acids with one or two individual strand 5' overhangs, method for production and use thereof
08/28/2003WO2002086112A3 Nucleic acid molecules encoding starch degrading enzymes
08/28/2003WO2002083720A3 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
08/28/2003WO2002081696A3 Oryza sativa nuclear cap binding protein 80
08/28/2003WO2002081675A3 Method for detecting homologous recombination events
08/28/2003WO2002081628A8 Modulation of gene expression associated with inflammation proliferation and neurite outgrowth, using nucleic acid based technologies
08/28/2003WO2002081521A3 Osteoprotegerin in milk
08/28/2003WO2002081517A3 Novel polypeptides and nucleic acids encoded thereby
08/28/2003WO2002079785A3 Phosphoprotein target for insulin and its antagonists
08/28/2003WO2002079453A3 Method for increasing the production of a secondary metabolite in a microorganism by introducing mutations that confer antibiotic-resistance
08/28/2003WO2002078603A3 Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine
08/28/2003WO2002077021A3 Streptococcus pneumoniae proteins and nucleic acids
08/28/2003WO2002074905A9 Leptin induced genes
08/28/2003WO2002074783A3 Modified interferon beta with reduced immunogenicity
08/28/2003WO2002074048A8 P-glycoproteins and uses thereof
08/28/2003WO2002072840A3 Process for the fermentative production of d-pantothenic acid
08/28/2003WO2002072823A3 Human g protein-coupled receptor
08/28/2003WO2002070735A3 Method for the amplification and detection of dna using a transcription based amplification
08/28/2003WO2002068687A3 Function and application of tob gene in central nervous system of mammal
08/28/2003WO2002068469A3 Modified thrombopoietin with reduced immunogenicity
08/28/2003WO2002066660A3 Method for identifying herbicidally active substances
08/28/2003WO2002066653A3 Procaryotic libraries and uses
08/28/2003WO2002064806A3 A process for the fermentative preparation of d-pantothenic acid and/or its salts
08/28/2003WO2002061092A3 Regulation of human lysyl oxidase
08/28/2003WO2002056030A3 Method and device for collecting and stabilizing a biological sample
08/28/2003WO2002054073A3 Latent human tuberculosis model, diagnostic antigens, and methods of use
08/28/2003WO2002048706A3 Compositions and methods for the synthesis and subsequent modification of uridine-5'-diphosphosulfoquinovose (udp-sq)
08/28/2003WO2002046467A3 Gene expression profiling of primary breast carcinomas using arrays of candidate genes
08/28/2003WO2002046443A3 Transcriptional regulator nucleic acids, polypeptides and methods of use thereof
08/28/2003WO2002045503A3 Transgenic mice containing targeted gene disruptions
08/28/2003WO2002044736A3 Diagnosis and treatment of epidermal or skin diseases
08/28/2003WO2002043478A3 Transgenic transchromosomal rodents for making human antibodies
08/28/2003WO2002042491A3 Method for identifying compounds or lead structures against rna target motifs and rna/protein interactions
08/28/2003WO2002040661A3 TRANSGENIC MICE CONTAINING Kir2.3 POTASSIUM K+ CHANNEL GENE DISRUPTIONS
08/28/2003WO2002040539A3 Gpcr-like protein and nucleic acids encoding same
08/28/2003WO2002036820A3 Methods for assessing the risk of non-insulin-dependent diabetes mellitus based on allelic variations in the 5'-flanking region of the insulin gene and body fat
08/28/2003WO2002036627A3 Interferons, uses and compositions related thereto
08/28/2003WO2002036149A3 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof
08/28/2003WO2002034940A3 Methods for screening compounds that modulate lipid metabolism
1 ... 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 ... 4023